How to Deal<br />By Rev Shark<br />RealMoney.com Contributor<br />5/11/2009 8:33 AM EDT <br /><br />"Confidence comes not from always being right but from not fearing to be wrong." <br /><br />-- Peter T. McIntyre <br />Given how shallow the pullbacks have been in this market over the past couple months, it shouldn't be surprising that there is a now a very high level of confidence that the worst is over. For nearly two months, we haven't seen more than a couple negative days in a row as the aggressiveness of the dip buyers has been consistent and strong. <br /><br />The idea that this rally is just a bear market bounce is steadily losing steam as there has been so little weakness for so long. The bears are being worn out and run over. The consensus now is that the stimulus plans and financial plans are working sufficiently to avert a collapse of the financial system. There is still plenty of debate over the pace at which things will improve, but the market is acting like it has completely dismissed the idea that the economy is still in free-fall. <br /><br />Even the bears seem to be given up on the idea that we will revisit the market lows. They are mainly focused on the idea that the market has gone too far, too fast and is in need of a rest. Maybe when that happens, and we do rest, then their pessimism will increase, but presently they are just looking for momentum to cool. <br /><br />So how do we deal with the stock market from this point? There are a huge number of stocks that have already made big moves and many are now quite extended. If you have been waiting for a pullback, you haven't seen much of one, and if you didn't jump in very fast, you have had great difficulty trying to gain long exposure. Many of the biggest moves out there have been by secondary stocks as momentum traders have hunted for action and created it on their own. <br /><br />Certainly, we would be foolish to expect the recent momentum to continue unabated. Markets like this will need to rest, but market players aren't going away. Even when we do have weakness in one part of the market, they are moving to another. For example, on Friday technology was weak, but energy and commodities did well, as the hot money looked for some place else to go. <br /><br />More than ever, this is a market in which you have to stick to the good charts and use good money management. That means that you make sure to take some profits into strength when you have them and keep stops tight and cut your losses should momentum fizzle. <br /><br />Anticipating that this uptrend will end is a very tough game to play. For weeks now we have been talking about how we need a rest, but the buyers keep on jumping in as soon as weaken just a little. At some point, this dip buying is going to be punished badly, but it is so persistent that it's the bears that have been punished and who have grown skittish. <br /><br />This morning the financials are looking a bit weak as the market digests news about how they are going to raise the capital they need. However, Morgan Stanley (MS) has an upgrade, and George Soros is sounding bullish. <br /><br />There is no question we are going to rest here soon. It is just a matter of for how long and whether it starts to impact the mood when momentum finally does cool. The bulls still have the benefit of the doubt, but the hurdles are getting higher. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: CNO +37.2%, VM +12.8% (light volume), PMI +11.8%, GSI +9.0%, HOGS +7.9% (light volume), FEED +6.3%, DISH +5.8%, CRZO +3.7% (light volume)... M&A news: CF +5.0% (Agrium Increases Offer for CF Industries to $40.00 in Cash Plus One Agrium Share Per CF Share)... A few financials showing strength: HBAN +7.7%, FITB +5.4%, RF +2.9%... Other news: TCM +49.5% (still checking), PBCT +7.5% (Cramer makes positive comments on MadMoney), AZN +6.8% (AstraZeneca's Brilinta drug beats Plavix in clinical trial - DJ), STAR +3.0% (Cramer makes positive comments on MadMoney)... Analyst comments: ANDS +17.0% (upgraded to Buy at ThinkEquity), AEO +7.4% (upgraded to Buy at Lazard Capital Mkts and upgraded to Buy at Citigroup), IPSU +6.3% (upgraded to Buy at BWS Financial), HMA +4.2% (upgraded to Buy at Citigroup), LNC +3.2% (seeing early strength; hearing added to Buy List at tier 1 firm), HOT +2.3% (upgraded to Overweight at JPMorgan), IP +1.3% (upgraded to Buy from Neutral at Goldman- Reuters).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: CPSL -21.4%, ALD -13.0%, AOB -12.3%, BPZ -10.7%, CPBY -10.3%, SLW -4.6%, HBC -3.8%, ENER -2.9%... M&A news: AGU -2.1% (Agrium increases offer for CF Industries to $40.00 in cash plus one Agrium share per CF Share)... Select financials pulling back: COF -8.1% (announces public offering of 56 mln shares of common stock), IRE -7.9%, BCS -6.4%, RBS -6.0%, AIG -4.5%, LYG -3.9%, KEY -3.9% (confirms capital raise of $750 million), BAC -3.5% (Bank of America selling CCB stake - WSJ), C -3.2% (MUFG may cancel purchase of Citi unit, according to report - WSJ), AZ -3.2%, MTU -2.5% (Mitsubishi UFJ Financial Group has decided to purchase shares of common stock of Morgan Stanley in the public offering), JPM -2.3%, CS -2.1%, WFC -1.9% (confirms common stock offering, raises $8.6 bln)... Select oil/gas related names trading lower: SNP -6.7%, E -3.3%, BP -3.3%, RDS.A -2.6%, TOT -2.4%... Select metals/mining names showing weakness: GOLD -4.0%, RTP -3.7%, BBL -3.6%, BHP -3.3%... Select shipping names trading lower premarket: DRYS -6.3%, EXM -5.8%, FRO -3.6%... Other news: AFL -3.6% (files for a senior debt/subordinated debt securities shelf offering for an indeterminate amount), STP -3.3% (Suntech Power to manufacture solar products in the U.S.)... Analyst comments: CBG -7.6% (trading lower in early trade; hearing downgraded to Sell at tier 1 firm), MU -4.5% (downgraded to Neutral at UBS), CTV -4.0% (downgraded to Neutral at UBS), LOW -2.7% (downgraded to Market Perform at Bernstein), NOK -2.6% (downgraded to Neutral at GC Research), VLO -2.6% (ticking lower in early trade; hearing downgraded to Sell at tier 1 firm), HD -2.2% (downgraded to Market Perform at Bernstein), COST -2.0% (downgraded to Neutral from Buy at Goldman- Reuters), CLX -1.3% (downgraded to Underperform at Bernstein).